Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("INSINGA, Ralph P")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

A Review of Health-Utility Data for Osteoarthritis : Implications for Clinical Trial-Based EvaluationRUCHLIN, Hirsch S; INSINGA, Ralph P.PharmacoEconomics (Auckland). 2008, Vol 26, Num 11, pp 925-935, issn 1170-7690, 11 p.Article

The health and economic burden of genital warts in a set of private health plans in the United StatesINSINGA, Ralph P; DASBACH, Erik J; MYERS, Evan R et al.Clinical infectious diseases. 2003, Vol 36, Num 11, pp 1397-1403, issn 1058-4838, 7 p.Article

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US : Analytic framework and review of the literatureINSINGA, Ralph P; DASBACH, Erik J; ELBASHA, Elamin H et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 11, pp 1107-1122, issn 1170-7690, 16 p.Article

Newborn screening with tandem mass spectrometry: Examining its cost-effectiveness in the Wisconsin Newborn Screening PanelINSINGA, Ralph P; LESSIG, Ronald H; HOFFMAN, Gary L et al.The Journal of pediatrics. 2002, Vol 141, Num 4, pp 524-531, issn 0022-3476Article

Pap screening in a U.S. health planINSINGA, Ralph P; GLASS, Andrew G; RUSH, Brenda B et al.Cancer epidemiology, biomarkers & prevention. 2004, Vol 13, Num 3, pp 355-360, issn 1055-9965, 6 p.Article

Acute/subacute herpes zoster : Healchcare resource utilisation and costs in a group of US health plansINSINGA, Ralph P; ITZLER, Robbin F; PELLISSIER, James M et al.PharmacoEconomics (Auckland). 2007, Vol 25, Num 2, pp 155-169, issn 1170-7690, 15 p.Article

Diagnoses and outcomes in cervical cancer screening: A population-based studyINSINGA, Ralph P; GLASS, Andrew G; RUSH, Brenda B et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 1, pp 105-113, issn 0002-9378, 9 p.Article

The health care costs of cervical human papillomavirus-related diseaseINSINGA, Ralph P; GLASS, Andrew G; RUSH, Brenda B et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 1, pp 114-120, issn 0002-9378, 7 p.Article

Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women : An evaluation from multiple analytic perspectivesINSINGA, Ralph P; DASBACH, Erik J; ELBASHA, Elamin H et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 4, pp 709-715, issn 1055-9965, 7 p.Article

Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and diseaseDASBACH, Erik J; ELBASHA, Elamin H; INSINGA, Ralph P et al.Epidemiologic reviews. 2006, Vol 28, pp 88-100, issn 0193-936X, 13 p.Article

A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United StatesINSINGA, Ralph P; LIAW, Kai-Li; JOHNSON, Lisa G et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 7, pp 1611-1622, issn 1055-9965, 12 p.Article

The incidence of herpes zoster in a United States administrative databaseINSINGA, Ralph P; ITZLER, Robbin F; PELLISSIER, James M et al.Journal of general internal medicine. 2005, Vol 20, Num 8, pp 748-753, issn 0884-8734, 6 p.Article

Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection ClearanceINSINGA, Ralph P; PEREZ, Gonzalo; BROWN, Darron R et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 2, pp 287-296, issn 1055-9965, 10 p.Article

Human Papillomavirus Infections and Vulvar Disease DevelopmentGARLAND, Suzanne M; INSINGA, Ralph P; SINGS, Heather L et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 6, pp 1777-1784, issn 1055-9965, 8 p.Article

Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health PlansWHITE, Ronald R; LENHART, Greg; SINGHAL, Puneet K et al.PharmacoEconomics (Auckland). 2009, Vol 27, Num 9, pp 781-792, issn 1170-7690, 12 p.Article

Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young WomenINSINGA, Ralph P; PEREZ, Gonzalo; ELBASHA, Elamin H et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 6, pp 1585-1594, issn 1055-9965, 10 p.Article

Impact of a prophylactic quadrivalent human papillomavirus (types 6,11,16,18) L1 virus-like particle vaccine in a sexually active population of North American womenBARR, Eliav; GAUSE, Christine K; BAUTISTA, Oliver M et al.American journal of obstetrics and gynecology. 2008, Vol 198, Num 3, pp 261-263, issn 0002-9378, 3 p.Article

  • Page / 1